LGC
CELG

Laurel Grove Capital’s Celgene Corp CELG Stock Holding History

Laurel Grove Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,350
Closed -$350K – 103
2016
Q3 		$350K Sell
3,350
-800
-19% -$86.6K 0.2% 87
2016
Q2 		$409K Buy
4,150
+150
+4% +$15.5K 0.25% 80
2016
Q1 		$400K Buy
4,000
+100
+3% +$10.3K 0.23% 84
2015
Q4 		$467K Sell
3,900
-150
-4% -$17.4K 0.26% 79
2015
Q3 		$438K Sell
4,050
-50
-1% -$6.21K 0.25% 81
2015
Q2 		$475K Buy
4,100
+100
+3% +$11.4K 0.25% 77
2015
Q1 		$461K Buy
+4,000
New +$478K 0.25% 76

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Laurel Grove Capital's CELG Position: Q4 2016 in Review

Laurel Grove Capital sold out of Celgene Corp (CELG) in Q4 2016, closing a stake of 3,350 shares — an estimated $350K sold.

Laurel Grove Capital first reported a position in CELG in Q1 2015 and held it in 7 quarters. The position peaked at $475K in Q2 2015. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

  • Laurel Grove Capital reported no remaining Celgene Corp position as of Q4 2016 after selling out during the quarter.
  • Laurel Grove Capital sold 3,350 Celgene Corp shares in Q4 2016, an estimated $350K.
  • Laurel Grove Capital first reported a position in Celgene Corp in Q1 2015 and held it in 7 quarters.
  • Laurel Grove Capital's Celgene Corp position peaked at $475K in Q2 2015.
  • 1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on Laurel Grove Capital's 13F filing for Q4 2016, filed 11 Jan 2017.